GLP-1 & Incretin Therapies
Semaglutide, tirzepatide and next-generation weight-loss medications.
ExploreGSOD 2027MAY 27-28SINGAPORE
“The Cardiometabolic Era: Advances in Obesity, Diabetes, and Weight Management.”
An intimate two-day congress convening endocrinologists, nutritionists and metabolic scientists shaping the future of weight care.
Semaglutide, tirzepatide and next-generation weight-loss medications.
ExploreSleeve gastrectomy, gastric bypass and metabolic surgery outcomes.
ExplorePediatric prevention, early intervention and family-based care.
ExploreMonogenic obesity, GWAS findings and precision weight medicine.
ExploreInsulin resistance, NAFLD and cardiometabolic risk.
ExploreNutrition counseling, physical activity and CBT.
ExploreEarly-bird through July 14, 2026. All fees include two-day access, kit, lunches and the welcome reception.
Valid full-time student ID required at check-in.
Attend every session, every poster, every break.
Oral or poster — after abstract acceptance.
Virtual rates start at $199·Group of 3+ saves another 10% per seat·See full pricing details
Save 20% on fees
Next upFinal submissions due
Author notifications
Two days
Academicians, scientists, R&D and industry professionals, policy-makers, founders, and graduate / doctoral students working in cardiology and adjacent fields.
Open the Register page on the main site, choose your participation mode and category, and submit the secure online form. Early-bird applies until July 14, 2026.
No — the hotel is a separate optional add-on. You can book at the negotiated rate inside the registration form once the venue is announced.
Yes — but only for registered, paid-up participants. Once your payment is confirmed, a personalised invitation letter is issued within 3-5 business days.
Each author may submit up to two abstracts, in oral, poster, or a combination of both formats.
No travel, food or accommodation funding is offered. The 50% early-bird and 10% group rate are the available cost-savers.
Early-bird ends July 14, 2026.